Advancing gene editing efficiency and precision with the Pin-point™ Base Editing Platform

Gene editing is a critical capability, particularly in the fast-growing field of cell and gene therapy. However, scientists must take care that their gene edits do not result in unintended consequences. Technologies like CRISPR-Cas9 can generate multiplex edits, but the required multiple double strand breaks in the host cell genome may lead to cell toxicity, off-target editing, and unwanted genomic rearrangements.

Watch this on-demand webinar to learn how base editing with the novel Pin-point™ platform can achieve efficient and precise complex multiplex edits of cell lines, while decreasing the potential of unintended consequences.

In this webinar, you will learn:

• How to achieve gene editing across multiple cell lines with improved precision.
• What the critical considerations are for base editing of cell lines.
• Why the Pin-point platform is highly effective at targeting multiple genes of interest simultaneously.
• How Revvity’s Preclinical Services team use the Pin-point platform in a high-throughput workflow.

The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.